Patent · US Active

Pyrazole derivatives as MALT1 inhibitors

US11040031B2 · kind B2 · utility

1Cited by

12References

9Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Tianbao Lu · Collegeville, US
Peter J. Connolly · New Providence, US
Maxwell D. Cummings · Strafford, US
Joseph Kent Barbay · Flourtown, US
Kevin D. Kreutter · Plainsboro, US
Tongfei Wu · Leuven, BE
Gaston Stanislas Marcella Diels · Turnhout, BE
Jan Willem Thuring · Hamden, US
Ulrike PHILIPPAR · Ekeren, BE
James P. Edwards · San Diego, US
Fang Shen · Amherst, US

Key dates

Filing date	Jun 13, 2019
Grant date	Jun 22, 2021
Priority date	—
Expiry date	Jun 13, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/056
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, and G, are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.